PNC Financial Services Group’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $358K | Buy |
23,750
+2,933
| +14% | +$51.2K | ﹤0.01% | 2034 |
|
|
2026
Q1 | $399K | Sell |
20,817
-1,530
| -7% | -$33.2K | ﹤0.01% | 1846 |
|
|
2025
Q4 | $491K | Buy |
22,347
+1,192
| +6% | +$21.5K | ﹤0.01% | 1676 |
|
|
2025
Q3 | $257K | Buy |
21,155
+201
| +1% | +$2.72K | ﹤0.01% | 2127 |
|
|
2025
Q2 | $391K | Buy |
20,954
+1,719
| +9% | +$34K | ﹤0.01% | 1736 |
|
|
2025
Q1 | $369K | Sell |
19,235
-3,004
| -14% | -$87.9K | ﹤0.01% | 1744 |
|
|
2024
Q4 | $801K | Buy |
22,239
+2,720
| +14% | +$92K | ﹤0.01% | 1266 |
|
|
2024
Q3 | $828K | Buy |
19,519
+5,247
| +37% | +$222K | ﹤0.01% | 1251 |
|
|
2024
Q2 | $575K | Buy |
14,272
+8,639
| +153% | +$360K | ﹤0.01% | 1412 |
|
|
2024
Q1 | $199K | Sell |
5,633
-155
| -3% | -$4.15K | ﹤0.01% | 2170 |
|
|
2023
Q4 | $171K | Buy |
5,788
+2,562
| +79% | +$53.1K | ﹤0.01% | 2260 |
|
|
2023
Q3 | $67K | Buy |
3,226
+1,099
| +52% | +$30.2K | ﹤0.01% | 2799 |
|
|
2023
Q2 | $52.2K | Sell |
2,127
-3,170
| -60% | -$102K | ﹤0.01% | 3034 |
|
|
2023
Q1 | $215K | Buy |
5,297
+3,184
| +151% | +$132K | ﹤0.01% | 2100 |
|
|
2022
Q4 | $95K | Sell |
2,113
-4,715
| -69% | -$213K | ﹤0.01% | 2592 |
|
|
2022
Q3 | $327K | Sell |
6,828
-314
| -4% | -$17.2K | ﹤0.01% | 1772 |
|
|
2022
Q2 | $422K | Buy |
7,142
+896
| +14% | +$73.6K | ﹤0.01% | 1636 |
|
|
2022
Q1 | $726K | Buy |
6,246
+164
| +3% | +$19.1K | ﹤0.01% | 1408 |
|
|
2021
Q4 | $916K | Buy |
6,082
+482
| +9% | +$65.1K | ﹤0.01% | 1338 |
|
|
2021
Q3 | $669K | Buy |
5,600
+438
| +8% | +$48.3K | ﹤0.01% | 1437 |
|
|
2021
Q2 | $504K | Sell |
5,162
-335
| -6% | -$29.9K | ﹤0.01% | 1597 |
|
|
2021
Q1 | $484K | Buy |
5,497
+571
| +12% | +$53.1K | ﹤0.01% | 1587 |
|
|
2020
Q4 | $472K | Buy |
4,926
+1,228
| +33% | +$127K | ﹤0.01% | 1514 |
|
|
2020
Q3 | $420K | Buy |
3,698
+263
| +8% | +$27.6K | ﹤0.01% | 1443 |
|
|
2020
Q2 | $341K | Sell |
3,435
-920
| -21% | -$73.4K | ﹤0.01% | 1604 |
|
|
2020
Q1 | $281K | Buy |
4,355
+4,280
| +5,707% | +$300K | ﹤0.01% | 1621 |
|
|
2019
Q4 | $4K | Sell |
75
-4,151
| -98% | -$256K | ﹤0.01% | 3701 |
|
|
2019
Q3 | $249K | Buy |
4,226
+1,874
| +80% | +$120K | ﹤0.01% | 2011 |
|
|
2019
Q2 | $152K | Buy |
2,352
+865
| +58% | +$55.8K | ﹤0.01% | 2324 |
|
|
2019
Q1 | $94K | Buy |
1,487
+332
| +29% | +$17.4K | ﹤0.01% | 2588 |
|
|
2018
Q4 | $44K | Buy |
+1,155
| New | +$40.8K | ﹤0.01% | 2944 |
|
|
2018
Q1 | – | Sell |
-12
| Closed | – | – | 4276 |
|
|
2017
Q4 | $0 | Hold |
12
| – | – | ﹤0.01% | 4243 |
|
|
2017
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 4228 |
|
|
2017
Q2 | $0 | Hold |
12
| – | – | ﹤0.01% | 4226 |
|
|
2017
Q1 | $0 | Buy |
12
+10
| +500% | +$219 | ﹤0.01% | 4208 |
|
|
2016
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 4095 |
|
|
2016
Q3 | $0 | Sell |
2
-674
| -100% | -$49.2K | ﹤0.01% | 4267 |
|
|
2016
Q2 | $50K | Sell |
676
-220
| -25% | -$17.7K | ﹤0.01% | 2839 |
|
|
2016
Q1 | $78K | Sell |
896
-208
| -19% | -$18.2K | ﹤0.01% | 2613 |
|
|
2015
Q4 | $130K | Hold |
1,104
| – | – | ﹤0.01% | 2318 |
|
|
2015
Q3 | $98K | Buy |
1,104
+2
| +0.2% | +$233 | ﹤0.01% | 2536 |
|
|
2015
Q2 | $120K | Buy |
1,102
+360
| +49% | +$44.8K | ﹤0.01% | 2529 |
|
|
2015
Q1 | $94K | Buy |
742
+658
| +783% | +$85.6K | ﹤0.01% | 2730 |
|
|
2014
Q4 | $10K | Buy |
+84
| New | +$11.6K | ﹤0.01% | 3378 |
|
|
2014
Q3 | – | Sell |
-1,040
| Closed | -$170K | – | 4054 |
|
|
2014
Q2 | $170K | Buy |
1,040
+247
| +31% | +$42K | ﹤0.01% | 2013 |
|
|
2014
Q1 | $175K | Buy |
+793
| New | +$202K | ﹤0.01% | 1954 |
|
Other funds holding TNDM
PIM
YIH
AIMCA
PNC Financial Services Group's TNDM Position: Q2 2026 in Review
PNC Financial Services Group increased its Tandem Diabetes Care (TNDM) stake by 14% in Q2 2026, buying an estimated $51.2K and bringing the position to 23,750 shares worth $358K. The position accounts for ﹤0.01% of the portfolio, ranked #2034.
PNC Financial Services Group first reported a position in TNDM in Q1 2014 and has held it in 46 quarters since. The position peaked at $916K in Q4 2021. 106 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- PNC Financial Services Group held 23,750 shares of Tandem Diabetes Care worth $358K as of Q2 2026.
- PNC Financial Services Group bought 2,933 Tandem Diabetes Care shares in Q2 2026, an estimated $51.2K.
- Tandem Diabetes Care made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2034 holding.
- PNC Financial Services Group first reported a position in Tandem Diabetes Care in Q1 2014 and has held it in 46 quarters since.
- PNC Financial Services Group's Tandem Diabetes Care position peaked at $916K in Q4 2021.
- 106 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.